Prostatype Genomics appoints Sedermera Fondkommission as liquidity provider for the company´s share
The liquidity providing commences on June 17, 2021Sedermera Fondkommission will in its assignment as liquidity provider continuously provide trading orders on both bid- and ask side in the orderbook for the Prostatype Genomics share and also ensure that a predetermined spread is kept in the share. The purpose with liquidity providing is to promote a good liquidity in the share and ensure a low spread between bid and ask prices in the continuous trading.